Peptech
Private Company
Funding information not available
Overview
PepTech is a long-established, private contract research and manufacturing organization (CRMO) focused on peptide and small molecule chemistry. The company leverages a team of approximately 300 chemists and ISO 9001-certified operations in China to deliver custom synthesis, a catalog of specialty amino acids, and medicinal chemistry support to over 1,000 customers worldwide. Its business model is purely service- and product-based, generating revenue by supporting the R&D pipelines of other companies rather than developing its own therapeutic assets. PepTech's value proposition centers on rapid feasibility, reliable execution, and global scale for drug discovery teams.
Technology Platform
Integrated chemistry services platform specializing in peptide and small molecule synthesis, featuring a deep catalog of specialty amino acids/chiral building blocks, custom synthesis, medicinal chemistry support, and process R&D/scale-up capabilities, supported by ISO 9001-certified R&D and manufacturing facilities in China.
Opportunities
Risk Factors
Competitive Landscape
PepTech competes in the fragmented contract research and manufacturing organization (CRMO) market. Competitors range from large, full-service CDMOs (e.g., Lonza, Catalent, Thermo Fisher) to numerous small, specialized chemistry shops. Its differentiation lies in its specific focus on peptide/amino acid chemistry, its integrated China-based platform, and its positioning as a 'premium' partner for discovery and early development.